China Energy Storage Technology Development Limited — M&A Activity 2018

Jun 1, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [96 x 91] intentionally omitted <==

CHINA HEALTHCARE ENTERPRISE GROUP LIMITED 華 夏 健 康 產 業 集 團 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

EXTENSION OF LONG STOP DATE FOR THE MAJOR TRANSACTION

Reference is made to the announcements of China Healthcare Enterprise Group Limited (the ‘‘Company’’) dated 11 October 2017, 9 February 2018 and 29 March 2018 respectively (collectively, the ‘‘Announcements’’) and the circular of the Company dated 15 February 2018 (the ‘‘Circular’’), each in relation to a proposed acquisition. Unless otherwise defined herein, capitalized terms used herein shall have the same meanings as those defined in the Announcements and the Circular.

As disclosed in the Announcements and the Circular, all of the conditions precedent shall be satisfied on or before the Long Stop Date (unless the parties have agreed in writing to extend the Long Stop Date for fulfilment of any of the relevant conditions). As additional time is required for the parties to satisfy certain conditions precedent under the Sale and Purchase Agreement and the Supplemental Agreement, the Purchaser and the Vendor have agreed to further extend the Long Stop Date from 31 May 2018 to 6 July 2018.

Save as disclosed above, all other terms and conditions of the Sale and Purchase Agreement and the Supplemental Agreement shall remain unchanged and continue in full force and effect in all respects.

– 1 –

The Acquisition is subject to a number of conditions precedent which may or may not be fulfilled. Shareholders and potential investors are reminded to exercise caution when dealing in the Shares.

By order of the Board China Healthcare Enterprise Group Limited Gong Shaoxiang Chairman and Executive Director

Hong Kong, 31 May 2018

As at the date of this announcement, the Board comprises Mr. Gong Shaoxiang (Chairman), Mr. Lee Chi Hwa Joshua, Mr. Duan Chuanhong and Mr. Shi Xinbiao as executive Directors, Mr. Cao Yuyun as non-executive Director and Mr. Bao Jinqiao, Mr. Wong Chun Hung and Mr. Leung Pok Man as independent non-executive Directors.

– 2 –